INVESTOR RELATIONS

Founded in 2014, Prenetics is a major global diagnostics and genetic testing company with the mission to bring health closer to millions of people globally and decentralize healthcare by making the three pillars — Prevention, Diagnostics and Personalized Care — comprehensive and accessible to anyone, at anytime and anywhere.

Key Financials –
FY2021 Earnings

FY2021 Revenue $275.9m +323% YoY

FY2021 Adjusted EBITDA
$40.9m

Forecast 2025 Revenue +$600m

Laboratory and rapid
at-home tests 22 million+

Prenetics Delivers Exceptional FY2021 Results as Company Completes Business Combination with Artisan Acquisition Corp. to list on Nasdaq Stock Exchange

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

10 Nov 22

16 Sep 22

09 Sep 22

08 Aug 22

INVESTOR RELATIONS

Key Financials –
FY2021 Earnings

Stock Information

Press Releases

Recent Events

Featured Reports

INVESTOR RELATIONS

Key Financials – FY2021 Earnings

Stock Information

Press Releases

Recent Events

Featured Reports

Key Financials –
FY2021 Earnings